#VisualAbstract: Blinatumomab Improves Survival in MRD-Negative Acute Lymphoblastic Leukemia in Adults
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 6, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 5, 2024
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 3, 2024
Click here to read this study in JAMA Network. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreAug 2, 2024
Click here to read this study in the NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreAug 1, 2024
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreAug 1, 2024
Click to read the study in JAMA Network Open ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 30, 2024
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 27, 2024
Click here to read this study in Lancet Oncology. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreJul 25, 2024
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreJul 23, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 23, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 20, 2024
1. In this randomized controlled trial, oral sebetralstat provided faster times to the beginning of symptom relief than placebo in individuals experiencing hereditary angioedema attacks. 2. Oral sebetralstat also provided larger...
Read MoreJul 19, 2024
Click here to read this study in Lancet Oncology. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreJul 18, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 16, 2024
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 13, 2024
Click here to read this study in Nature Medicine. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreJul 13, 2024
Click here to read this study in the Lancet. ©2024 2 Minute Medicine, Inc. All rights reserved....
Read MoreJul 12, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 11, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read MoreJul 10, 2024
1. The complete response rates (pathological and clinical) were similar (~55%) in both groups. 2....
Read More